TT&A advised HSBC, MUFG and Standard Chartered Bank on the USD 1.2 billion acquisition financing for Biocon Biologics Limited

November 2022, Banking and Finance

TT&A advised HSBC, MUFG and Standard Chartered Bank on the USD 1.2 billion acquisition financing for Biocon Biologics Limited

TT&A was the Indian legal advisor to HSBC, MUFG and Standard Chartered Bank (the arrangers) in connection with a term loan facility of up to USD 1.2 billion availed by a UK subsidiary of Biocon Biologics Limited in connection with acquisition of the biosimilars business of the Viatris group.

TT&A Team: Sonali Mahapatra & Nidhi Rani – Partners; and Kunal Bhatia – Senior Associate

Previous PostTT&A advised Dalmia Bharat Refractories Limited in transfer of its refractories business to RHI Magnesita India LimitedNext PostTT&A advised Asian Development Bank (“ADB”) in relation to definitive documentation entered with ABIS Exports India Private Limited for a proposed debenture issuance to support the construction of a micro fish feed plant training farmers in climate-resilient fish farming practices

TT&A advised HSBC, MUFG and Standard Chartered Bank on the USD 1.2 billion acquisition financing for Biocon Biologics Limited

Sonali Mahapatra

Nidhi Rani

Practice Areas

Disclaimer